{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:15:20Z","timestamp":1793776520114,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease course. This longitudinal, prospective, multi-centre-study of German MS-patients aimed to detect socio-demographic, clinical, or psychological determinants of attitudes towards standard vaccines, SARS-CoV-2 vaccines, and governmental measures before\/during the pandemic. Exactly 404 MS-patients were investigated by standardized questionnaires and structured interviews on socio-demographic, clinical-neurological, and psychological characteristics, vaccination status, and vaccination from June 2019. Data on SARS-CoV-2 vaccination willingness were collected in two follow-up assessments (1st: June to July 2020, before SARS-CoV-2 vaccine availability, N\u2009=\u2009200; 2nd: March to May 2021, after SARS-CoV-2 vaccine availability, N\u2009=\u2009157). Age, sex, MS course type, depression, and personality characteristics (Extraversion, Novelty seeking, Self-directedness, and Cooperativeness) were significantly associated with vaccination willingness. Although the majority of MS-patients showed SARS-CoV-2 vaccination willingness at both follow-ups (1st: 60%, 2nd: 61%), a substantial proportion had concerns and were undecided or opposed to vaccination. Socio-demographic variables like age and sex, psychopathological status, and various personality characteristics might influence vaccination willingness and should be considered when discussing with MS-patients about SARS-CoV-2 vaccination.<\/jats:p>","DOI":"10.1038\/s41598-022-18912-3","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T12:10:46Z","timestamp":1662639046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-958X","authenticated-orcid":false,"given":"Felicita","family":"Heidler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Baldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4655-774X","authenticated-orcid":false,"given":"Niklas","family":"Frahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvan Elias","family":"Langhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Mashhadiakbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Streckenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Burian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe Klaus","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5823-9618","authenticated-orcid":false,"given":"J\u00f6rg","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"18912_CR1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int."},{"key":"18912_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2020.107278","volume":"50","author":"AJ Marian","year":"2021","unstructured":"Marian, A. J. Current state of vaccine development and targeted therapies for COVID-19: Impact of basic science discoveries. Cardiovasc. Pathol. 50, 107278 (2021).","journal-title":"Cardiovasc. Pathol."},{"key":"18912_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/jnnp-2021-326839","volume":"92","author":"T Monschein","year":"2021","unstructured":"Monschein, T. et al. Vaccination and multiple sclerosis in the era of the COVID-19 pandemic. J. Neurol. Neurosurg. Psychiatry 92, 1033\u20131043 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"18912_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102822","volume":"56","author":"M Pawlitzki","year":"2020","unstructured":"Pawlitzki, M. et al. Merits and culprits of immunotherapies for neurological diseases in times of COVID-19. EBioMedicine 56, 102822 (2020).","journal-title":"EBioMedicine"},{"key":"18912_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2215-0366(20)30168-1","volume":"7","author":"EA Holmes","year":"2020","unstructured":"Holmes, E. A. et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 7, 547\u2013560 (2020).","journal-title":"Lancet Psychiatry"},{"key":"18912_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25594","volume":"3","author":"S Kreps","year":"2020","unstructured":"Kreps, S. et al. Factors associated with US adults\u2019 likelihood of accepting COVID-19 vaccination. JAMA Netw. Open 3, e2025594 (2020).","journal-title":"JAMA Netw. Open"},{"key":"18912_CR7","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1007\/s11606-020-05898-9","volume":"35","author":"CL Park","year":"2020","unstructured":"Park, C. L. et al. Americans\u2019 COVID-19 stress, coping, and adherence to CDC guidelines. J. Gen. Intern. Med. 35, 2296\u20132303 (2020).","journal-title":"J. Gen. Intern. Med."},{"key":"18912_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2020.575950","volume":"11","author":"S Taylor","year":"2020","unstructured":"Taylor, S. et al. A proactive approach for managing COVID-19: The importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Front Psychol 11, 575950 (2020).","journal-title":"Front Psychol"},{"key":"18912_CR9","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1016\/j.vaccine.2020.10.027","volume":"38","author":"S Bell","year":"2020","unstructured":"Bell, S., Clarke, R., Mounier-Jack, S., Walker, J. L. & Paterson, P. Parents\u2019 and guardians\u2019 views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 38, 7789\u20137798 (2020).","journal-title":"Vaccine"},{"key":"18912_CR10","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1016\/j.vaccine.2020.08.043","volume":"38","author":"PL Reiter","year":"2020","unstructured":"Reiter, P. L., Pennell, M. L. & Katz, M. L. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?. Vaccine 38, 6500\u20136507 (2020).","journal-title":"Vaccine"},{"key":"18912_CR11","unstructured":"Ochel, P., Eitze, S., Seufert, A. & Betsch, C. Ergebnisse aus dem COVID-19 Snapshot MOnitoring COSMO, L\u00e4ngsschnitt Th\u00fcringen, Erhebung 1-3: Zwischenstand der aktuellen Lage. https:\/\/projekte.uni-erfurt.de\/cosmo2020\/files\/COSMO_TH_W3.pdf."},{"key":"18912_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107724","volume":"97","author":"A Bendau","year":"2021","unstructured":"Bendau, A., Plag, J., Petzold, M. B. & Str\u00f6hle, A. COVID-19 vaccine hesitancy and related fears and anxiety. Int. Immunopharmacol. 97, 107724 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"18912_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/WCO.0000000000000824","volume":"33","author":"L Moiola","year":"2020","unstructured":"Moiola, L., Rommer, P. S. & Zettl, U. K. Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis. Curr. Opin. Neurol. 33, 286\u2013294 (2020).","journal-title":"Curr. Opin. Neurol."},{"key":"18912_CR14","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1177\/1352458518799580","volume":"25","author":"PS Rommer","year":"2019","unstructured":"Rommer, P. S. et al. Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry. Mult Scler. 25, 1641\u20131652 (2019).","journal-title":"Mult Scler."},{"key":"18912_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2016.21","volume":"12","author":"A Winkelmann","year":"2016","unstructured":"Winkelmann, A., Loebermann, M., Reisinger, E. C., Hartung, H.-P. & Zettl, U. K. Disease-modifying therapies and infectious risks in multiple sclerosis. Nat Rev Neurol 12, 217\u2013233 (2016).","journal-title":"Nat Rev Neurol"},{"key":"18912_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang, L., Wang, F.-S. & Gershwin, M. E. Human autoimmune diseases: A comprehensive update. J. Intern. Med. 278, 369\u2013395 (2015).","journal-title":"J. Intern. Med."},{"key":"18912_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Primers 4, 43 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"18912_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. Multiple Sclerosis. N. Engl. J. Med. 378, 169\u2013180 (2018).","journal-title":"N. Engl. J. Med."},{"key":"18912_CR19","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J., Baranzini, S. E., Geurts, J., Hemmer, B. & Ciccarelli, O. Multiple sclerosis. Lancet 391, 1622\u20131636 (2018).","journal-title":"Lancet"},{"key":"18912_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102164","volume":"41","author":"F Haji Akhoundi","year":"2020","unstructured":"Haji Akhoundi, F., Sahraian, M. A. & Naser Moghadasi, A. Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients. Mult Scler. Relat. Disord. 41, 102164 (2020).","journal-title":"Mult Scler. Relat. Disord."},{"key":"18912_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.autrev.2015.11.005","volume":"15","author":"R Patejdl","year":"2016","unstructured":"Patejdl, R., Penner, I. K., Noack, T. K. & Zettl, U. K. Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration. Autoimmun. Rev. 15, 210\u2013220 (2016).","journal-title":"Autoimmun. Rev."},{"key":"18912_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.autrev.2017.07.004","volume":"16","author":"R Patejdl","year":"2017","unstructured":"Patejdl, R. & Zettl, U. K. Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. Autoimmun. Rev. 16, 925\u2013936 (2017).","journal-title":"Autoimmun. Rev."},{"key":"18912_CR23","first-page":"1","volume":"Report 20","author":"MK Akmatov","year":"2020","unstructured":"Akmatov, M. K., Holstiege, J., Steffen, A. & B\u00e4tzing, J. Vaccination against seasonal influenza infection among chronically ill individuals\u2014An analysis of outpatient claims data from 2009 to 2018. Versorgungsatlas Report 20, 1\u201320 (2020).","journal-title":"Versorgungsatlas"},{"key":"18912_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102788","volume":"49","author":"DM Ehde","year":"2021","unstructured":"Ehde, D. M., Roberts, M. K., Herring, T. E. & Alschuler, K. N. Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States. Mult Scler. Relat. Disord. 49, 102788 (2021).","journal-title":"Mult Scler. Relat. Disord."},{"key":"18912_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102880","volume":"51","author":"F Serrazina","year":"2021","unstructured":"Serrazina, F., Sobral Pinho, A., Cabral, G., Salavisa, M. & Correia, A. S. Willingness to be vaccinated against COVID-19: An exploratory online survey in a Portuguese cohort of multiple sclerosis patients. Mult Scler. Relat. Disord. 51, 102880 (2021).","journal-title":"Mult Scler. Relat. Disord."},{"key":"18912_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.635245","volume":"8","author":"P Borah","year":"2021","unstructured":"Borah, P. et al. Perspectives on RNA vaccine candidates for COVID-19. Front. Mol. Biosci. 8, 635245 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"18912_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ageing\/afaa274","volume":"50","author":"RL Soiza","year":"2021","unstructured":"Soiza, R. L., Scicluna, C. & Thomson, E. C. Efficacy and safety of COVID-19 vaccines in older people. Age Age. 50, 279\u2013283 (2021).","journal-title":"Age Age."},{"key":"18912_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41582-022-00646-5","volume":"18","author":"A Winkelmann","year":"2022","unstructured":"Winkelmann, A., Loebermann, M., Barnett, M., Hartung, H.-P. & Zettl, U. K. Vaccination and immunotherapies in neuroimmunological diseases. Nat. Rev. Neurol. 18, 289\u2013306 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"18912_CR29","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3389\/fimmu.2019.01883","volume":"10","author":"T Zrzavy","year":"2019","unstructured":"Zrzavy, T. et al. Vaccination in multiple sclerosis: Friend or foe?. Front. Immunol. 10, 1883 (2019).","journal-title":"Front. Immunol."},{"key":"18912_CR30","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10198-020-01208-6","volume":"21","author":"S Neumann-B\u00f6hme","year":"2020","unstructured":"Neumann-B\u00f6hme, S. et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur. J. Health Econ. 21, 977\u2013982 (2020).","journal-title":"Eur. J. Health Econ."},{"key":"18912_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n699","volume":"372","author":"J Wise","year":"2021","unstructured":"Wise, J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ 372, n699 (2021).","journal-title":"BMJ"},{"key":"18912_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1590\/0004-282X20140234","volume":"73","author":"AB de Lima","year":"2015","unstructured":"de Lima, A. B., Paes, R. A. & Alvarenga, R. M. P. Personality factors in recently diagnosed multiple sclerosis patients: A preliminary investigation with the NEO-FFI scale. Arq. Neuropsiquiatr. 73, 200\u2013204 (2015).","journal-title":"Arq. Neuropsiquiatr."},{"key":"18912_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173 (2018).","journal-title":"Lancet Neurol."},{"key":"18912_CR34","first-page":"104","volume":"85","author":"F Heidler","year":"2022","unstructured":"Heidler, F. et al. Vaccination setting of patients with autoimmune diseases in times of severe acute respiratory syndrome coronavirus type 2 pandemic using the example of multiple sclerosis patients: A longitudinal multicenter study. ENE 85, 104\u2013111 (2022).","journal-title":"ENE"},{"key":"18912_CR35","unstructured":"German Standing Committee on Vaccination (STIKO). Immunisation Schedule. https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/Materialien\/Downloads-Impfkalender\/Impfkalender_Englisch.pdf?__blob=publicationFile."},{"key":"18912_CR36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J. F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33, 1444\u20131444 (1983).","journal-title":"Neurology"},{"key":"18912_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1001\/archpsyc.1993.01820240059008","volume":"50","author":"CR Cloninger","year":"1993","unstructured":"Cloninger, C. R., Svrakic, D. M. & Przybeck, T. R. A psychobiological model of temperament and character. Arch. Gen. Psychiatry 50, 975\u2013990 (1993).","journal-title":"Arch. Gen. Psychiatry"},{"key":"18912_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1017\/S0007125000161896","volume":"181","author":"CR Brewin","year":"2002","unstructured":"Brewin, C. R. et al. Brief screening instrument for post-traumatic stress disorder. Br. J. Psychiatry 181, 158\u2013162 (2002).","journal-title":"Br. J. Psychiatry"},{"key":"18912_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1034\/j.1600-0447.2003.00062.x","volume":"107","author":"JM Quintana","year":"2003","unstructured":"Quintana, J. M. et al. Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. Acta Psychiatr. Scand. 107, 216\u2013221 (2003).","journal-title":"Acta Psychiatr. Scand."},{"key":"18912_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1073191110368482","volume":"18","author":"ES Schwartz","year":"2011","unstructured":"Schwartz, E. S., Chapman, B. P., Duberstein, P. R., Weinstock-Guttman, B. & Benedict, R. H. B. The NEO-FFI in Multiple Sclerosis: Internal consistency, factorial validity, and correspondence between self and informant reports. Assessment 18, 39\u201349 (2011).","journal-title":"Assessment"},{"key":"18912_CR41","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0191-8869(00)00173-2","volume":"31","author":"N Schmitz","year":"2001","unstructured":"Schmitz, N., Hartkamp, N., Baldini, C., Rollnik, J. & Tress, W. Psychometric properties of the German version of the NEO-FFI in psychosomatic outpatients. Pers. Individ. Differ. 31, 713\u2013722 (2001).","journal-title":"Pers. Individ. Differ."},{"key":"18912_CR42","first-page":"205521732110171","volume":"7","author":"XM Xiang","year":"2021","unstructured":"Xiang, X. M. et al. COVID-19 vaccination willingness among people with multiple sclerosis. Mult Scler. J. Exp. Transl. Clin. 7, 205521732110171 (2021).","journal-title":"Mult Scler. J. Exp. Transl. Clin."},{"key":"18912_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248372","volume":"16","author":"D Graeber","year":"2021","unstructured":"Graeber, D., Schmidt-Petri, C. & Schr\u00f6der, C. Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany. PLoS ONE 16, e0248372 (2021).","journal-title":"PLoS ONE"},{"key":"18912_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/cid\/ciaa433","volume":"71","author":"J McAteer","year":"2020","unstructured":"McAteer, J., Yildirim, I. & Chahroudi, A. The VACCINES Act: Deciphering vaccine hesitancy in the time of COVID-19. Clin. Infect. Dis. 71, 703\u2013705 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"18912_CR45","unstructured":"Deutsches \u00c4rzteblatt. Pfizer rechnet mit Milliardenumsatz durch Coronaimpfstoff. https:\/\/www.aerzteblatt.de\/nachrichten\/128712\/Pfizer-rechnet-mit-Milliardenumsatz-durch-Coronaimpfstoff."},{"key":"18912_CR46","unstructured":"Deutsches \u00c4rzteblatt. Biontech erwirtschaftet betr\u00e4chtlichen Nettogewinn. https:\/\/www.aerzteblatt.de\/nachrichten\/128908\/Biontech-erwirtschaftet-betraechtlichen-Nettogewinn."},{"key":"18912_CR47","doi-asserted-by":"publisher","first-page":"964","DOI":"10.7326\/M20-3569","volume":"173","author":"KA Fisher","year":"2020","unstructured":"Fisher, K. A. et al. Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults. Ann. Intern. Med. 173, 964\u2013973 (2020).","journal-title":"Ann. Intern. Med."},{"key":"18912_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.25122\/jml-2020-0184","volume":"14","author":"S Saeed","year":"2021","unstructured":"Saeed, S. et al. Knowledge, attitude and practice towards COVID-19 among individuals with associated comorbidities. J. Med. Life 14, 225\u2013237 (2021).","journal-title":"J. Med. Life"},{"key":"18912_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13584-021-00458-w","volume":"10","author":"MS Green","year":"2021","unstructured":"Green, M. S., Abdullah, R., Vered, S. & Nitzan, D. A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel\u2014Implications for vaccination implementation policies. Isr. J. Health Policy Res. 10, 26 (2021).","journal-title":"Isr. J. Health Policy Res."},{"key":"18912_CR50","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1007\/s00415-020-10160-7","volume":"268","author":"ND Chiaravalloti","year":"2021","unstructured":"Chiaravalloti, N. D. et al. The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. J. Neurol. 268, 1598\u20131607 (2021).","journal-title":"J. Neurol."},{"key":"18912_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102512","volume":"46","author":"AC Vogel","year":"2020","unstructured":"Vogel, A. C., Schmidt, H., Loud, S., McBurney, R. & Mateen, F. J. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study. Mult Scler. Relat. Disord. 46, 102512 (2020).","journal-title":"Mult Scler. Relat. Disord."},{"key":"18912_CR52","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3389\/fpsyg.2020.01491","volume":"11","author":"N Ozamiz-Etxebarria","year":"2020","unstructured":"Ozamiz-Etxebarria, N., Idoiaga Mondragon, N., Dosil Santamar\u00eda, M. & Picaza Gorrotxategi, M. Psychological symptoms during the two stages of lockdown in response to the COVID-19 outbreak: An investigation in a sample of citizens in Northern Spain. Front. Psychol. 11, 1491 (2020).","journal-title":"Front. Psychol."},{"key":"18912_CR53","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1177\/0020764020927051","volume":"66","author":"S \u00d6zdin","year":"2020","unstructured":"\u00d6zdin, S. & Bayrak \u00d6zdin, \u015e. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. Int. J. Soc. Psychiatry 66, 504\u2013511 (2020).","journal-title":"Int. J. Soc. Psychiatry"},{"key":"18912_CR54","doi-asserted-by":"publisher","first-page":"7772","DOI":"10.3390\/ijerph18157772","volume":"18","author":"A El-Far Cardo","year":"2021","unstructured":"El-Far Cardo, A., Kraus, T. & Kaifie, A. Factors that shape people\u2019s attitudes towards the COVID-19 pandemic in Germany\u2014The influence of MEDIA, politics and personal characteristics. Int. J. Environ. Res. Public Health 18, 7772 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"18912_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1126\/science.373.6551.147","volume":"373","author":"M Wadman","year":"2021","unstructured":"Wadman, M. Journal retracts paper claiming COVID-19 vaccines kill. Science 373, 147 (2021).","journal-title":"Science"},{"key":"18912_CR56","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1126\/science.373.6554.479","volume":"373","author":"M Wadman","year":"2021","unstructured":"Wadman, M. The overlooked superpower of mRNA vaccines. Science 373, 479 (2021).","journal-title":"Science"},{"key":"18912_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2635","volume":"375","author":"PD Thacker","year":"2021","unstructured":"Thacker, P. D. Covid-19: Researcher blows the whistle on data integrity issues in Pfizer\u2019s vaccine trial. BMJ 375, n2635 (2021).","journal-title":"BMJ"},{"key":"18912_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00648-4","author":"A Singanayagam","year":"2021","unstructured":"Singanayagam, A. et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: A prospective, longitudinal, cohort study. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(21)00648-4 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"18912_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2211","volume":"374","author":"V Male","year":"2021","unstructured":"Male, V. Menstrual changes after covid-19 vaccination. BMJ 374, n2211 (2021).","journal-title":"BMJ"},{"key":"18912_CR60","unstructured":"Paul-Ehrlich-Institut\u2014Coronavirus und COVID-19\u2014Sicherheit von COVID-19-Impfstoffen. https:\/\/www.pei.de\/DE\/newsroom\/dossier\/coronavirus\/arzneimittelsicherheit.html."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18912-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18912-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18912-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:50:32Z","timestamp":1664974232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18912-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18912"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18912-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15147"}}